Meike Brinker

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Chronic Kidney Disease

Skeletal Muscle

Top Venues

Journal of the American Society of Nephrology : JASN

Nature medicine

Diabetes, obesity & metabolism

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Muthiah Vaduganathan, Gerasimos Filippatos, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Alasdair Henderson, Meike Brinker, Peter Kolkhof, Patrick Schloemer, James Lay-Flurrie, Prabhakar Viswanathan, Carolyn Su Ping Lam, Michele Senni, Sanjiv J Shah, Carolyn S P Lam, Faiez Zannad, Ellen Burgess, Luis M Ruilope, Stefan D Anker, Bertram Pitt, Rajiv Agarwal, John Joseph Valentine McMurray, Scott D Solomon
Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: the FINE-HEART pooled analysis of cardiovascular, kidney, and mortality outcomes. Nature medicine (2024)
Dustin J Little, Samvel B Gasparyan, Patrick Schloemer, Niels Jongs, Meike Brinker, Martin Karpefors, Christoph Tasto, Nicole Mentenich, Lars Frison, Richard Nkulikiyinka, Jerome Rossert, Hiddo J Lambers Heerspink
Validity and Utility of a Hierarchical Composite Endpoint for Clinical Trials of Kidney Disease Progression: A Review. Journal of the American Society of Nephrology : JASN (2023)
Thomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, Martijn van Noort, Martijn Ruppert, Martijn van Noort, Dirk Garmann, Joerg Lippert, Roland Heinig, Meike Brinker, Hiddo J Lambers Heerspink
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD. Diabetes, obesity & metabolism (2023)
Hiddo J Lambers Heerspink, Niels Jongs, Patrick Schloemer, Dustin J Little, Meike Brinker, Christoph Tasto, Martin Karpefors, David Collins Wheeler, George L Bakris, Vlado Perkovic, Richard Nkulikiyinka, Jerome Rossert, Samvel B Gasparyan
Development and Validation of a New Hierarchical Composite Endpoint for Clinical Trials of Kidney Disease Progression. Journal of the American Society of Nephrology : JASN (2023)
Sebastiaan Camiel Goulooze, Hiddo J Lambers Heerspink, Martijn van Noort, Nelleke Snelder, Meike Brinker, Joerg Lippert, Thomas Eissing
Dose-Exposure-Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD. Clinical pharmacokinetics 61 (7) (2022)